MedTrace Logo

Application of Serial Body Composition Change for Risk Prediction in Treating Patients With Severe Pneumonia

NCT04396522 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 194

Last updated 2023-09-06

No results posted yet for this study

Summary

We hypothesize that serial changes of body composition in patients with pneumonia can help clinician to monitor prognosis. It was associated with underlying immune response.

Conditions

Interventions

DEVICE

noninvasively Bio-electrical Impedance Analysis (BIA)

By means of noninvasively Bio-electrical Impedance Analysis (BIA) to measure body composition, which divides body weight into different components such as lean body mass and fat mass.

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Principal Investigators

  • WEN-FENG Fang

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2023-01-09
Completion
2023-02-21
FDA Device
Yes

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04396522 on ClinicalTrials.gov